Perioperative management with upfront combination therapy in a patient exhibiting
idiopathic pulmonary hypertension with central pulmonary thrombosis.
[6,7,8] The burden of pulmonary hypertension is likely to be different in India in contrast to the western world, where
Idiopathic Pulmonary hypertension and pulmonary hypertension related to left heart disease, particularly coronary artery disease predominate.
Angiopoietin/Tie2 pathway influences smooth muscle hyperplasia in
idiopathic pulmonary hypertension. Am J Respir Crit Care Med 2006; 174: 1025-1033, doi: 10.1164/rccm.200602-304OC.
-
Idiopathic Pulmonary Hypertension Global Clinical Trials Review, H2, 2014
[USPRwire, Mon Nov 03 2014] GlobalData's clinical trial report, "
Idiopathic Pulmonary Hypertension Global Clinical Trials Review, H2, 2014" provides data on the
Idiopathic Pulmonary Hypertension clinical trial scenario.
Washington, Dec 31 (ANI): Scientists from Johns Hopkins Children's Centre are conducting a study to identify several biomarkers for
idiopathic pulmonary hypertension (IPH).
Pulmonary vascular resistance is chronically elevated in pulmonary arterial diseases such as scleroderma,
idiopathic pulmonary hypertension (IPAH--previously called primary pulmonary hypertension) and chronic thromboembolism.
Older studies have estimated the incidence of
idiopathic pulmonary hypertension to be one to two cases per million, with autopsy studies showing a prevalence of 1,300 per million.
Idiopathic pulmonary hypertension is a rare disease characterized by sustained elevation of the pulmonary artery pressure and pulmonary vascular resistance, normal pulmonary artery wedge pressure, in the absence of a known cause.
Primary pulmonary hypertension, also known as unexplained or
idiopathic pulmonary hypertension, has no known cause.
TAPSE [Tricuspid Annular Plane Systolic Excursion] has been correlated with mortality in patients of systemic sclerosis with pulmonary hypertension and
idiopathic pulmonary hypertension.
In another study, apelin and BNPT levels were compared in patients with chronic parenchymal lung disease,
idiopathic pulmonary hypertension and heart failure.